logo
College kids, an old drug, and why it's everywhere again

College kids, an old drug, and why it's everywhere again

USA Today14-01-2025

College kids, an old drug, and why it's everywhere again
Show Caption
Hide Caption
What is 'galaxy gas'? What to know about new dangerous trend
Nitrous oxide, the ingredient in laughing gas, is now being called 'galaxy gas' on social media. Young folks are taking a whiff, getting high and posting about it, creating a dangerous trend.
Fox - Fox 29
An old drug has taken on new popularity — and it has doctors concerned.
Once known by nicknames like laughing gas and hippy crack, the inhalant nitrous oxide — a sedative commonly used by healthcare providers — is getting attention online.
In a TikTok with over 4.4 million views, Hootie Hurley, one half of a touring DJ group that frequently performs fraternity shows, talked about watching inhalant abuse unfold at a fraternity house.
'We walk into the president's chambers (at the fraternity) … and there's three dudes carrying, like, Butane tanks,' Hurley said. 'And they're going, 'keep going, keep going, keep going!'' as a student huffed the gas. Hurley says he witnessed the student pass out for several seconds; and he met a woman later in the evening who was also huffing, which illustrated to him the behavior wasn't contained to a single group of students or fraternity.
Inhalant abuse isn't new. But drug abuse experts say the prevalence of smoke shops and accessibility of online shopping have made it easier for people to purchase nitrous oxide containers in large quantities. At the same time, social media posts — even negative ones — about huffing have emboldened teens and young people to try it and contributed to its normalization.
How does nitrous oxide function as a drug?
Nitrous oxide is a short-acting sedative that slows down the nervous system by restricting oxygen flow to the brain, producing a high. The substance produces vapors that can lead to short-term impaired vision and speech as well as nausea and drowsiness. It can also have more dangerous side effects like heart failure and long-term memory, attention and judgment problems, according to the National Institute of Drug Abuse. Long-term use of inhalants is also associated with mood and anxiety disorders such as depression.
'For really high volume, longer term use, there's actually nerve conduction function impairment, and some cognitive function impairment," says Cleveland Clinic Pediatric Pulmonologist Dr. John Carl.
The drug is often sold in small canisters called whippets or whip-its, nicknamed after aerosol chargers that propel whipped cream out of a canister. But some users, like the students Hurley referenced in the video, inhale gas directly from large tanks, increasing the risk of effects.
Selling and purchasing nitrous oxide for its intended purpose is legal, but some states have outlawed recreational use of the gas. The Food and Drug Administration (FDA) regulates nitrous oxide under its Food Drug and Cosmetics Act.
Good news on teen vaping? Rates have dropped, but another product worries tobacco watchdogs
Growing usage on college campuses
It's not the first time the drug's usage has gone viral. During Mardi Gras last February, videos showed thousands of steel cartridges lining Tulane University frat houses.
'I had no idea what whippets were before I came to Tulane,' says Tulane sophomore Alya Satchu, who added that the streets near campus were full of 'empty, little metal canisters' during the celebration. 'It was just something that I had become used to at this point, that this was the culture at Tulane.'
West Virginia University also recorded a spike in mouth and throat injuries in October 2024 due to inhalant abuse and warned students of potential frostbite and chill burns around the mouth, throat and fingers as a result of the low-temperature of the nitrous oxide.
The majority of the injuries were from whippets, according to WMU Student Health and Urgent Care Medical Director Dr. Carmen Burrell.
Inhalant abuse isn't new, but experts worry it's making a comeback
Huffing has been around for decades. In the '90s, there was a '7th Heaven' episode about kids who huffed paint fumes that gained attention and was even shown in some schools to warn students of the dangers.
What is making the rounds today isn't all that different.
Aerosols, along with gases like halothane, nitrous oxide, butane and more all fit under the umbrella of inhalants, according to the Substance Abuse and Mental Health Services Administration. But while abuse of glue, felt-tip markers and spray paints were depicted in 1990s and 2000s pop culture, today, gases — particularly nitrous oxide — have risen as the most notable form of inhalant abuse among teens and young adults.
Still, inhalant abuse is less prevalent than party drugs like ecstasy or cocaine. In 2023, less than 1% of people ages 12 and older reported using inhalants. But unlike those drugs, nitrous oxide doesn't leave a trail, meaning it slips by in routine drug tests.
Burrell said whippets' availability online has made it easier for students to purchase nitrous oxide containers in large quantities. Part of the product's appeal is affordability.
Sites like Miami Magic Infusions and Galaxy Gas sell whipped cream dispensers and nitrous oxide canisters intended for culinary use by baristas and chefs, but videos online show users abusing the products, which are available in colorful designs and fruity flavors.
What is Galaxy Gas? New 'whippets' trend with nitrous oxide products sparks concerns
Tulane University School of Social Work Dean Patrick Bordnick, who researches substance addiction, says employing such marketing tactics creates a false idea 'that this isn't a harmful thing.'
'Put two and two together, and you have almost an analog to the e-cigarette scenario,' Bordnick says, referring to how e-cigarette companies initially only offered menthol and regular flavors before adding flavors like cotton candy and blue raspberry, which in turn caught the attention of young people. 'We're creating flavors and packaging and things that clearly target non-chefs.'
Parents should talk to their kids about it
For concerned parents, the first step is an increased awareness and the second is beginning a dialogue.
Carl says parents should open up a conversation with their kids about nitrous oxide while being aware of the modern stressors of being a young adult.
'There's an incredible amount of stress and depression and people are trying to escape,' Carl says. The rise in usage comes as young adults are experiencing anxiety, depression and mood disorders at severe levels.
As parents talk to their kids about drugs, it's important to keep those mental health concerns in mind.
Hale's role covering youth mental health at USA TODAY is funded by a grant from Pivotal Ventures. Pivotal Ventures does not provide editorial input. Reach her at rhale@usatoday.com and @rachelleighhale on X.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll
Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll

Yahoo

timean hour ago

  • Yahoo

Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll

Vast majority say there isn't enough staff in public hospitals, including 82 per cent of Ontario PC supporters TORONTO, June 09, 2025--(BUSINESS WIRE)--Nearly three in four Ontarians believe the government should prioritize spending on public hospitals rather than private clinics, in a poll conducted following the recent budget announcement of $280 million being shunted to private, for-profit clinics. Eighty-four per cent of Ontarians also said they believe public hospitals are understaffed. The Nanos poll was conducted between May 27 and June 1, surveying 1,017 Ontarians over the age of 18. The poll was commissioned by CUPE's Ontario Council of Hospital Unions (OCHU-CUPE), which released a supplementary report on the ongoing privatization of hospital services. "This poll shows there is overwhelming opposition to this government's plans to privatize hospital surgeries," said Michael Hurley, president of OCHU-CUPE, which represents 50,000 hospital and long-term care staff. "The public understands that spending on private, for-profit clinics and agencies is much more expensive, comes with poorer outcomes and duplicates infrastructure and administration. The vast majority wants our resources allocated to public health care." While the government expands funding to for-profit clinics, over four in five Ontarians (84%) believe there is not enough staff in public hospitals – including 82 per cent of Ontario PC supporters. In the recent budget health care funding increased two per cent, well below the annual health care inflation of 5.2 per cent, noted the union. After significant privatization of cataract surgeries, the government plans to expand private, for-profit delivery of other procedures including knee and hip replacements as well as diagnostics. In 2023, Premier Doug Ford suggested that up to 50 per cent of surgeries could be performed outside of hospitals. "This is startling given that for-profit surgeries in Ontario are twice as expensive as those performed in public hospitals," said Hurley. The OCHU-CUPE report highlights the findings of a 2024 Canadian Medical Association Journal study showing that privatization of cataract operations resulted in surgical rates increasing by 22 per cent for the wealthiest Ontarians while declining for everyone else. Access to surgeries for the poorest people in Ontario declined nine per cent. The study noted that hospitals provided equal access to care. At the media conference, the union showed a visual representation of this inequality through a map of Ontario's neighbourhoods, colour-coded by socioeconomic status. The yellow areas representing the wealthiest neighbourhoods showed the most affluent Ontarians are clustered in enclaves that are barely visible amidst a sea of blue (representing the bottom 80 per cent of residents). "People can't afford to pay thousands of dollars for health care," Hurley said. "The great majority of Ontarians reject this expensive privatization that bakes in inequalities and greatly reduces access." The Ontario Health Coalition has documented hundreds of cases of private, for-profit clinics billing patients for medically necessary services – which is illegal – and add-on services that patients felt compelled to purchase. Sixty-seven per cent of respondents to the Nanos poll said it was unacceptable for private clinics to charge people for medically necessary services. The union expressed concerns about the acceleration of privatization, citing the CMAJ study's findings showing that since expansion of public funding for cataract surgeries in Ontario, 22.5 per cent of these procedures were performed in private clinics. :gv/cope491 View source version on Contacts For more information please contact: Zee Noorsumar, CUPE Communications,znoorsumar@ 647-995-9859 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll
Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll

Business Wire

timean hour ago

  • Business Wire

Ontarians Want Provincial Government to Prioritize Spending on Public Hospitals Not Private Clinics: New Poll

TORONTO--(BUSINESS WIRE)--Nearly three in four Ontarians believe the government should prioritize spending on public hospitals rather than private clinics, in a poll conducted following the recent budget announcement of $280 million being shunted to private, for-profit clinics. Eighty-four per cent of Ontarians also said they believe public hospitals are understaffed. The Nanos poll was conducted between May 27 and June 1, surveying 1,017 Ontarians over the age of 18. The poll was commissioned by CUPE's Ontario Council of Hospital Unions (OCHU-CUPE), which released a supplementary report on the ongoing privatization of hospital services. 'This poll shows there is overwhelming opposition to this government's plans to privatize hospital surgeries,' said Michael Hurley, president of OCHU-CUPE, which represents 50,000 hospital and long-term care staff. 'The public understands that spending on private, for-profit clinics and agencies is much more expensive, comes with poorer outcomes and duplicates infrastructure and administration. The vast majority wants our resources allocated to public health care.' While the government expands funding to for-profit clinics, over four in five Ontarians (84%) believe there is not enough staff in public hospitals – including 82 per cent of Ontario PC supporters. In the recent budget health care funding increased two per cent, well below the annual health care inflation of 5.2 per cent, noted the union. After significant privatization of cataract surgeries, the government plans to expand private, for-profit delivery of other procedures including knee and hip replacements as well as diagnostics. In 2023, Premier Doug Ford suggested that up to 50 per cent of surgeries could be performed outside of hospitals. 'This is startling given that for-profit surgeries in Ontario are twice as expensive as those performed in public hospitals,' said Hurley. The OCHU-CUPE report highlights the findings of a 2024 Canadian Medical Association Journal study showing that privatization of cataract operations resulted in surgical rates increasing by 22 per cent for the wealthiest Ontarians while declining for everyone else. Access to surgeries for the poorest people in Ontario declined nine per cent. The study noted that hospitals provided equal access to care. At the media conference, the union showed a visual representation of this inequality through a map of Ontario's neighbourhoods, colour-coded by socioeconomic status. The yellow areas representing the wealthiest neighbourhoods showed the most affluent Ontarians are clustered in enclaves that are barely visible amidst a sea of blue (representing the bottom 80 per cent of residents). 'People can't afford to pay thousands of dollars for health care,' Hurley said. 'The great majority of Ontarians reject this expensive privatization that bakes in inequalities and greatly reduces access.' The Ontario Health Coalition has documented hundreds of cases of private, for-profit clinics billing patients for medically necessary services – which is illegal – and add-on services that patients felt compelled to purchase. Sixty-seven per cent of respondents to the Nanos poll said it was unacceptable for private clinics to charge people for medically necessary services. The union expressed concerns about the acceleration of privatization, citing the CMAJ study's findings showing that since expansion of public funding for cataract surgeries in Ontario, 22.5 per cent of these procedures were performed in private clinics. :gv/cope491

Japan Facial Injectables Market Set to Reach Valuation of US$ 1,121.31 Million by 2033
Japan Facial Injectables Market Set to Reach Valuation of US$ 1,121.31 Million by 2033

Yahoo

time2 hours ago

  • Yahoo

Japan Facial Injectables Market Set to Reach Valuation of US$ 1,121.31 Million by 2033

Japan facial injectables market is set to thrives with growth in natural beauty trends, technological innovations, and urban demand. Despite regulatory and rural challenges, cultural shifts and economic factors fuel sustained growth potential. Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The Japan facial injectables market was valued at US$ 508.18 million in 2024 and is projected to reach US$ 1,121.31 million by 2033, growing at a CAGR of 9.52% during the forecast period 2025–2033. The Japan facial injectables market is experiencing a significant shift in consumer behavior with a growing preference for subtle, natural-looking enhancements over dramatic transformations. Younger demographics, particularly those in their 20s and 30s, are increasingly opting for preventative treatments like botulinum toxin to delay signs of aging. Social media platforms, such as Instagram and TikTok, play a pivotal role in shaping beauty ideals, with influencers promoting injectables as a routine part of self-care. Moreover, there is a noticeable rise in male consumers seeking facial injectables, driven by societal acceptance of male grooming and professional competitiveness. Request Sample Pages: This trend aligns with Japan's cultural emphasis on "kawaii" (cuteness) and polished aesthetics, pushing demand for products that enhance facial harmony. According to a 2024 survey by the Japan Aesthetic Medicine Association, over 60,000 men underwent injectable treatments last year, a sharp increase from previous years. Clinics in urban hubs like Tokyo and Osaka report a surge in demand for hyaluronic acid fillers for jawline contouring and under-eye rejuvenation. Additionally, the rise of hybrid work environments has reduced downtime concerns, encouraging more individuals to schedule quick procedures. As consumer awareness grows, brands are focusing on personalized treatment plans, ensuring safety and satisfaction in this evolving landscape of the Japan facial injectables market. Key Findings in Japan Facial Injectables Market Market Forecast (2033) US$1,121.31 million CAGR 9.52% By Product Type Botulinum Toxin/Botox (55.97%) By Age Group 35-50 Year (51.72%) By Gender Female (81.62%) By Clinic Type Dermatology Clinics (35.45%) By Application Wrinkle Reduction (39.97%) Top Drivers Japan's rapidly aging society seeking non-surgical facial rejuvenation solutions Growing acceptance of aesthetic procedures among younger Japanese professionals Advanced injection techniques developed specifically for Asian facial anatomy Top Trends Micro-dosing approaches gaining popularity for natural-looking results in Japan Preventative treatments starting earlier among Tokyo millennials and Gen-Z AI-powered facial analysis integration in Japanese aesthetic clinics nationwide Top Challenges Strict PMDA regulations limiting new product approvals and innovations High training requirements creating certified injector shortages across prefectures Price sensitivity among middle-income consumers limiting market expansion potential Technological Breakthroughs Redefining Aesthetic Treatments In the Japan facial injectables market, technological innovation is a key growth driver with new formulations and delivery methods enhancing treatment precision and outcomes. Advanced micro-droplet injection techniques are gaining popularity for their ability to deliver natural-looking results, particularly for delicate areas like under-eyes. Additionally, AI-powered consultation tools are transforming patient experiences, enabling simulations of post-treatment results. Major brands are also developing longer-lasting fillers with biocompatible materials tailored to Asian skin types. A report by the Japan Society of Aesthetic Surgery (JSAS) indicates that over 92,000 procedures utilized cutting-edge injection technologies last year, reflecting rapid market adoption. For instance, Galderma's latest hyaluronic acid filler, designed for thinner skin textures common in Japanese patients, saw over 30,000 applications in clinics nationwide. The rise of telemedicine platforms has further democratized access, with over 25,000 virtual consultations recorded for injectables in 2024. These advancements not only improve patient satisfaction but also attract tech-savvy millennials. Stakeholders can capitalize on this trend by investing in training for practitioners on novel technologies and partnering with tech firms for digital tools, positioning themselves as leaders in the innovation-driven Japan facial injectables market. Navigating Regulatory Hurdles in Aesthetic Innovations The Japan facial injectables market operates under a stringent regulatory environment, prioritizing patient safety while posing challenges for market entrants. The Pharmaceuticals and Medical Devices Agency (PMDA) mandates rigorous clinical trials for new products, often requiring Japan-specific data, which delays launches compared to regions like the EU. Advertising restrictions further complicate brand visibility, as clinics cannot make direct claims about treatment outcomes without substantiated evidence, impacting consumer outreach. Recent PMDA data from 2024 shows that approval times for new injectables have been reduced to an average of 10 months, down from 14 months in prior years, thanks to digital submission processes. However, only 1,200 certified dermatologists and plastic surgeons were licensed to perform advanced injectable treatments last year, limiting service availability. High-profile adverse reaction cases, such as a 2023 Tokyo incident involving off-label filler use affecting 50 patients, have tightened post-market surveillance. For stakeholders, navigating this landscape requires robust compliance strategies and investment in local clinical research. Building partnerships with certified practitioners and focusing on transparent communication can help overcome barriers in the Japan facial injectables market, ensuring trust and market penetration. Disparities in Urban and Rural Demand Patterns In the Japan facial injectables market, a significant urban-rural divide shapes demand dynamics as of 2024, driven by economic and accessibility factors. Urban hubs like Tokyo, Osaka, and Nagoya account for the majority of procedures, fueled by higher disposable incomes and exposure to global beauty trends via media. In contrast, rural regions lag due to fewer specialized clinics, lower awareness, and cultural hesitancy toward cosmetic enhancements, often viewing them as unnecessary or vain. According to a study by the Japan Cosmetic Industry Association (JCIA), Tokyo recorded over 78,000 injectable procedures last year, while rural prefectures like Shimane reported fewer than 2,000. Urban clinics also cater to convenience-driven clients, offering extended hours and premium services, with over 35,000 bookings for same-day treatments in Osaka. Rural consumers often travel to cities, facing additional costs, with travel-related expenses for treatments estimated at over US$500 per trip for 10,000 individuals in 2024. Stakeholders can address this gap by deploying mobile clinics or partnering with telemedicine platforms to offer virtual consultations. Targeted awareness campaigns highlighting safety and benefits could also boost rural adoption in the Japan facial injectables market, unlocking untapped potential. Competitive Dynamics Among Aesthetic Industry Players: Top 3 Players Control Nearly 60% Market Share The Japan facial injectables market is fiercely competitive as of 2024, with global and local players battling for dominance through innovation and brand trust. International leaders like Allergan (Botox) Galderma, and Medytox Inc leverage their extensive portfolios and global reputation, focusing on products suited for Asian facial structures. These 3 players collectively hold over 60% market share. On the other hand, domestic firms, such as Koken Co., are gaining ground with cost-effective fillers and culturally aligned marketing, appealing to price-sensitive consumers seeking trusted local brands. A 2024 report from the Japan Aesthetic Research Institute (JARI) notes that Allergan conducted over 55,000 Botox procedures last year, while Koken's fillers were used in 28,000 treatments, reflecting growing local traction. Strategic collaborations are key, with Merz partnering with 300 Tokyo clinics in 2024 for exclusive training, enhancing practitioner expertise. Local players counter with affordability, pricing treatments US$50-100 lower per session than global brands. Social media campaigns, involving over 200 influencers last year, have also become critical for brand visibility. For stakeholders, differentiating through niche offerings—like male-specific treatments or eco-friendly fillers—and building practitioner networks can secure a foothold in the dynamic Japan facial injectables market, balancing global standards with local relevance. Cultural Nuances Influencing Beauty Treatment Choices Cultural nuances profoundly influence the Japan facial injectables market as of 2024, shaping beauty perceptions and treatment choices. The Japanese ethos of 'mottainai' (avoiding waste) extends to maintaining a youthful appearance as a form of self-care and respect. Subtlety is prized, with consumers favoring injectables for minor enhancements like smoothing nasolabial folds over bold transformations, distinguishing Japan from markets like South Korea, where dramatic changes are often sought. A survey by the Japan Beauty Institute (JBI) found that 72,000 respondents preferred fillers for natural corrections, with over 40,000 treatments focusing on fine lines. J-pop and anime aesthetics drive younger demographics, with 25,000 procedures last year inspired by idol-like features. However, conservative attitudes among older generations persist, with only 15,000 clients aged 50+ opting for injectables due to stigma. Clinics in the Japan facial injectables market are reframing treatments as wellness solutions, hosting over 100 awareness seminars in 2024 to destigmatize aesthetics. Stakeholders can tap into this cultural landscape by emphasizing natural results and aligning with local beauty ideals. Tailored campaigns targeting younger and male demographics could further accelerate adoption in the market, blending tradition with modern aspirations. Economic Factors Steering Aesthetic Spending Trends Economic factors significantly impact the Japan facial injectables market as of 2024, with disposable income and cost pressures shaping consumer behavior. Japan's economy faces challenges like wage stagnation, limiting spending on non-essential services for middle- and lower-income groups. Urban professionals, however, view injectables as a career investment, prioritizing image in competitive job markets. Economic disparities thus create a segmented market where affluent areas drive the bulk of demand. A economic analysis by the Japan Finance Ministry highlights that import costs for foreign injectables rose in the facial injectables market due to a weaker yen, increasing treatment prices by US$20-30 per session in over 500 clinics. Despite this, demand in high-income Tokyo districts saw 58,000 procedures last year. Post-pandemic recovery has spurred discretionary spending, with over 30,000 young professionals using annual bonuses for aesthetics in 2024. Medical tourism, supported by government initiatives, also shows promise, with 5,000 international clients seeking treatments last year. Stakeholders can navigate economic constraints by offering tiered pricing or payment plans, ensuring accessibility. Leveraging tourism by marketing Japan as an aesthetic hub could further boost the market, aligning economic strategies with consumer realities. Need Custom Data? Let Us Know: Future Horizons for Aesthetic Treatment Innovations Looking forward, the Japan facial injectables market is poised for robust growth with emerging trends offering significant opportunities for stakeholders. Personalized treatments, aided by genetic profiling for customized fillers, are on the horizon, while male and senior demographics present untapped markets. Sustainability is also gaining traction, with biodegradable fillers attracting eco-conscious clients. The market is set to benefit from Japan's aging population, projected to drive demand for rejuvenation treatments. A forecast by the Japan Aesthetic Technology Forum predicts 45,000 users will adopt AR-based consultation tools by next year, enhancing treatment planning. Rural expansion via mobile clinics could reach 20,000 new clients annually, based on pilot programs in 2024. Global investment in Japanese aesthetic R&D is also rising, with over US$10 million allocated to local startups last year for innovative injectables. Challenges like regulatory delays and economic pressures remain, but strategic partnerships with tech firms and localized marketing can mitigate risks. For stakeholders, focusing on education, accessibility, and niche innovations—such as male-specific products—will be key to capitalizing on the evolving Japan facial injectables market, positioning Japan as a global leader in aesthetic advancements. Japan Facial Injectables Market Major Players: Galderma Allergan Aesthetics Medytox Inc. Hugel Inc. HA Derma VAIM Global Inc Other Prominent Players Key Segmentation: By Product Type Botulinum Toxin/Botox Derma Fillers Collagen Hyaluronic Acid (HA) Fat Injection Calcium Hydroxylapatite (CaHA) Poly-L-lactic Acid (PLLA) Others By Age Group 18-34 Years 35-50 Years 51+ Years By Gender Male Female By Clinic Type MedSpa Dermatology Clinics Hospitals Plastic Surgery Centers Others By Application Wrinkle Reduction Face Line Correction Lip Augmentation Face Lift Facial Contouring Acne Scar Treatment Lipoatrophy Treatment Others Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store